Cargando…

Rationale einer dritten SARS-CoV-2-Impfung

Detalles Bibliográficos
Autor principal: Gillissen, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483803/
https://www.ncbi.nlm.nih.gov/pubmed/34595651
http://dx.doi.org/10.1007/s15006-021-0359-9
_version_ 1784577189051629568
author Gillissen, Adrian
author_facet Gillissen, Adrian
author_sort Gillissen, Adrian
collection PubMed
description
format Online
Article
Text
id pubmed-8483803
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-84838032021-10-01 Rationale einer dritten SARS-CoV-2-Impfung Gillissen, Adrian MMW Fortschr Med FB_Übersicht Springer Medizin 2021-10-07 2021 /pmc/articles/PMC8483803/ /pubmed/34595651 http://dx.doi.org/10.1007/s15006-021-0359-9 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle FB_Übersicht
Gillissen, Adrian
Rationale einer dritten SARS-CoV-2-Impfung
title Rationale einer dritten SARS-CoV-2-Impfung
title_full Rationale einer dritten SARS-CoV-2-Impfung
title_fullStr Rationale einer dritten SARS-CoV-2-Impfung
title_full_unstemmed Rationale einer dritten SARS-CoV-2-Impfung
title_short Rationale einer dritten SARS-CoV-2-Impfung
title_sort rationale einer dritten sars-cov-2-impfung
topic FB_Übersicht
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483803/
https://www.ncbi.nlm.nih.gov/pubmed/34595651
http://dx.doi.org/10.1007/s15006-021-0359-9
work_keys_str_mv AT gillissenadrian rationaleeinerdrittensarscov2impfung